MTIP AG: MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
(Basel, Switzerland): MTIP FUND II, SCSp is MTIP’s second healthtech fund, designed to provide growth capital and build on the healthtech investment thesis of its successful predecessor. With a target size of EUR 200m the fund invests in digital health and connected medical device companies, based primarily in Europe, that offer differentiated solutions for a rapidly evolving healthcare environment.
MTIP’s second fund executed a strong first closing securing EUR 130m. The capital was raised by different investors comprising mainly institutional investors, pension funds, family offices, hospitals, and foundations. The company is proud to work together with the European Investment Fund (EIF) as an anchor investor. EIF’s Chief Executive Alain Godard said: “MTIP’s fund strategy fits with EIF's ambition of financing the vital growth segment of the European Venture Capital ecosystem, which is largely underfunded and overly dependent on non-European investors for larger investments. The EIF is pleased to support MTIP and tackle two major gaps in the European market - digital health and growth capital.”
"This closing is an enormously important milestone in our company history, and we are pleased to have overachieved our expectations. Our Fund II has already added three stellar investments in Oviva, Trialbee and Koa Health to its portfolio with more to come soon. This creates a strong momentum towards the final close", emphasizes Dr. Christoph Kausch, Managing Partner of MTIP. The Fund continues to see a unique flow of investment opportunities, enhanced by the firm’s network, its leading role in Europe, and the strength of its strategy.
About MTIP
MTIP is a fast-growing pan-European healthtech growth capital investor, based in Basel Switzerland. We invest in digital health and digitally connected medical device companies, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors. Visit www.mtip.ch for more information
Contacts
Dr. Christoph KauschManaging Partner
communications@mtip.chLinks
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Valle Venia presents Sandgrain in Space LPS feat. Lara5.12.2025 10:15:00 CET | Press release
A Cosmic Song on Self Creation, Inner Rebirth, and the Quiet Power of Becoming
The German advertising market is facing another year of stagnation in 20263.12.2025 12:56:58 CET | Press release
The JOM Group’s latest advertising market forecast shows that the continuing economic uncertainty means that companies only have limited growth potential for increasing advertising investments.
Change in leadership at Visable: Patrick Sostmann to take over from Peter F. Schmid as CEO of Visable Group on January 1, 20262.12.2025 09:35:00 CET | Press release
(Hamburg, Germany) – After more than 13 years at the helm of Visable, Peter F. Schmid will hand over leadership of the Visable Group to Patrick Sostmann, who has been CCO at Visable since June 2025, on January 1, 2026. Visable operates the B2B marketplaces wer liefert was (wlw) and europages. The handover at the top underscores the company's continuous development and its close partnership with Alibaba.com. Sostmann will continue to drive forward the strategy based on AI investments and user orientation, thereby expanding the B2B marketplaces into European market leaders in digital B2B business. Over the past 13 years, Peter F. Schmid has transformed the long-established German business directory wer liefert was (wlw) into the internationally active digital company Visable, which now operates the two leading B2B marketplaces europages and wer liefert was (wlw). The last key milestone was Alibaba.com becoming majority shareholder in 2023. With these steps, Peter F. Schmid has set the co
PLAN-B NET ZERO sets new standards in the energy market with Neo Energy25.11.2025 13:34:49 CET | Press release
The Swiss green tech scale-up is positioning itself as a pioneer, transforming sustainable energy from a commodity into a digital lifestyle experience
Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 16:00:00 CET | Press release
Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

